project id: TCGA-GBM; case submitter id: TCGA-06-A5U0; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 2.04; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.36; rna integrity number: 9.4; age at index: 21; days to birth: -7958; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1991; age at diagnosis: 7958; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 815.0; icd 10 code: C71.4; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Occipital lobe; synchronous malignancy: No; tissue or organ of origin: Occipital lobe; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 48; initial weight: 390.0; oct embedded: false; preservation method: Unknown; sample id: b8187475-69da-4a02-a544-3435344daab8; sample submitter id: TCGA-06-A5U0-01A; portion id: f6de6957-86f7-456e-8465-45ef69784d4b; portion submitter id: TCGA-06-A5U0-01A-11; slide id: efd98c6d-f35c-45f9-a2aa-c76ef1c12fe9; slide submitter id: TCGA-06-A5U0-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 5.0; percent tumor cells: 85.0; percent tumor nuclei: 90.0; section location: TOP;